Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q4’24: No room for surprises

Scanfil

Scanfil’s performance is showing signs of a turnaround. In Q4, Scanfil's revenue decreased by 4% to 212 MEUR from a good comparison level, which was slightly above our forecast. Fundamentally the demand outlook should be improving. Head of research Antti Viljakainen summarizes.

NB! Due to a mic failure, the audio is not up to normal standards. We apologize for the poor audio quality.

00:00 Intro
00:14 O4 summarized
01:42 SRX acquisition
03:23 Inventory sold in Q4
04:47 Profitability
05:47 Outlook for the near future
08:04 Valuation & recommendation

Read the latest research: Expected return determined by earnings growth

Stay up to date
Analyst Interviews

Recent videos

AKTIER MED FRIIS - UGE 2 2026
09.01.2026, 12.00
HCA Morgenbørs 09/01 - Futures peger op i Europa og fokus på afgørelse om Trumps tariffer
09.01.2026, 09.28 Gubra
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026, 11.00 Herantis Pharma
HCA Morgenbørs 08/01 - Røde futures og fokus på kursmålsjusteringer
08.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus
07.01.2026, 09.58 RTX
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.